0872-671X

S0872-671X2022000200049

10.24950/rspmi.287

Portugal

30 06 2022

29 2 49 57

et ai 2018 6

2019 8

43-52

2021 22

7652

2020 70

86-104

2018 11

121

et ai 2019 25

625-38

2019 25

e123-7

Feldman SA.et ai 2015 385

517-28

2019 34

45-55

2022 28

159-74

Yescarta I European Medicines Agency

Kymriah I European Medicines Agency

2016 127

3321-30

2005 20

774-81

2020 383

2255-73

2022 22

85-96

National Cancer lnstitute - Division of Cancer Treatment & Diagnosis

Riviêre 1.Gonen M.Wang X.Sénéchal B.Curran KJ.et ai 2018 378

449

et ai 2018 15

47-62

2017 2017

9684909

et ai 2021 133

1318-25

et ai 2016 315

801

2018

2014 20

119-22

et ai 1885 2019

44-51

2019 15

323-35

et ai 2021 40

367

RoActemra I European Medicines Agency

2019 15

813-22

Sylvant I European Medicines Agency

et ai lnducible Caspase9-mediated suicide gene for MSC-based cancer gene therapy 2019 26

11-6

Kineret I European Medicines Agency

2019 18

125